Press Space to continue
Curated tech posts from X on AI, startups, and product development—signal without the doomscroll, updated on weekdays.
Press Space to continue
Press Space to continue
SITUATION DETECTED: A new Tufts Center analysis finds AI agents can accelerate cancer drug clinical development by about 10 weeks and cut late-stage trial costs by as much as $5.6 million, per Axios.